Monoclonal antibodies in clinical medicine.

Dick, Heather M.

doi:10.1136/bmj.291.6498.762

Cited by 10 publications

(1 citation statement)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These agents should become increasingly useful in detecting tumour cells and have potential for the imaging of lesions in deep tissues or the localisation of tumours in small foci inaccessible to other diagnostic tests. However Dick (1985) suggests that 'the greatest potential benefit is likely to be derived from the use of monoclonal antibodies as carriers of drugs or toxins for the effi cient localisation of cytotoxic treatments'. In addition to carrying conventional cytotoxic agents such as methotrexate and adriamycin, the use of radioisotope -labelled monoclonal antibodies -is also being studied in the context of cancer therapy (Baldwin and Byers, 1986).…”

Section: Future Influences On Disease Patternsmentioning

confidence: 99%

Health economics: Prospects for the future

1988

General Pharmacology: The Vascular System

View full text Add to dashboard Cite

The purpose of this book is to review the current state of health economics and look forward to developments over the next 25 years. The coverage is international, individual countries, areas and the World Health Organiza tion, being considered by world experts. Other topics examined include cost-benefit analysis and issues concerning the pharmaceutical industry. The book should represent a major statement of the field, of interest to economists and health planners.

show abstract

Section: Future Influences On Disease Patternsmentioning

confidence: 99%

Health economics: Prospects for the future

1988

General Pharmacology: The Vascular System

View full text Add to dashboard Cite

show abstract

Monoclonal antibodies and immobilized antibodies

Linhardt¹,

Abell²,

Denney³

et al. 1987

Appl Biochem Biotechnol

View full text Add to dashboard Cite

Antibodies in both their free and immobilized state have been the object of considerable industrial and academic interest. A variety of methods are used for preparing and immobilizing antibodies. Applications for monoclonal antibodies include the preparation of therapeutics, diagnostics, and in affinity fractionation. Recent US patents on monoclonal and immobilized antibodies and scientific literature on monoclonal antibodies are surveyed. A description of these patents and a list of references are given.

show abstract